A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy

Thromb Haemost. 2006 Jan;95(1):192-4.
No abstract available

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / therapeutic use*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / metabolism
  • Cytochrome P-450 CYP2C9
  • Drug Monitoring
  • Exons / genetics
  • Female
  • Genotype
  • Humans
  • Middle Aged
  • Mutation
  • Warfarin / administration & dosage
  • Warfarin / pharmacokinetics
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases